Perinatal exposure to the selective serotonin reuptake inhibitor citalopram alters spatial learning and memory, anxiety, depression, and startle in Sprague-Dawley rats

International Journal of Developmental Neuroscience

Volumn 54, Issue , 2016, Pages 39-52

  Sprowles, Jenna L N ^a   Hufgard, Jillian R ^a,b   Gutierrez, Arnold ^a,b   Bailey, Rebecca A ^a,b   Jablonski, Sarah A ^a   Williams, Michael T ^a,b   Vorhees, Charles V ^a,b  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Antidepressant; Autism related behavior; Citalopram; Developmental neurotoxicity; Rat; SSRI

Indexed keywords

AMPHETAMINE; CITALOPRAM; DIZOCILPINE; AMPHETAMINE DERIVATIVE; DIZOCILPINE MALEATE; NEUROPROTECTIVE AGENT; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; AUTISM; CINCINNATI WATER MAZE TEST; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; ELEVATED ZERO MAZE TEST; EMBRYO; EXPERIMENTAL SOCIAL BEHAVIOR TEST; FEMALE; FORCED SWIM TEST; GESTATIONAL AGE; IMMOBILITY; LATENT PERIOD; MALE; MARBLE BURYING TEST; MAZE TEST; MORRIS WATER MAZE TEST; NONHUMAN; OPEN FIELD TEST; PERINATAL DRUG EXPOSURE; PREPULSE INHIBITION DISRUPTION TEST; PRIORITY JOURNAL; PUP (RODENT); RAT; SENSORY GATING; SOCIAL PREFERENCE TEST; SPATIAL LEARNING; SPATIAL MEMORY; SPRAGUE DAWLEY RAT; STARTLE REFLEX; AGE; ANIMAL; BODY WEIGHT; CHEMICALLY INDUCED; DRUG EFFECTS; EXPLORATORY BEHAVIOR; NEWBORN; PATHOPHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE; PSYCHOLOGY; SEX DIFFERENCE; SWIMMING;

AGE FACTORS; AMPHETAMINES; ANIMALS; ANIMALS, NEWBORN; ANXIETY; BODY WEIGHT; CITALOPRAM; DEPRESSION; DIZOCILPINE MALEATE; EXPLORATORY BEHAVIOR; FEMALE; MALE; MAZE LEARNING; NEUROPROTECTIVE AGENTS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; SENSORY GATING; SEROTONIN UPTAKE INHIBITORS; SEX FACTORS; SPATIAL LEARNING; SWIMMING;

EID: 84986332652     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2016.08.007     Document Type: Article

References (130)

1. Altman, J., Bayer, S.A., Migration and distribution of two populations of hippocampal granule cell precursors during the perinatal and postnatal periods. J. Comp. Neurol. 301:3 (1990), 365–381, 10.1002/cne.903010304.
2. Altman, J., Bayer, S.A., Mosaic organization of the hippocampal neuroepithelium and the multiple germinal sources of dentate granule cells. J. Comp. Neurol. 301:3 (1990), 325–342, 10.1002/cne.903010302.
3. Alwan, S., Friedman, J.M., Safety of selective serotonin reuptake inhibitors in pregnancy. CNS Drugs 23:6 (2009), 493–509, 10.2165/00023210-200923060-00004.
4. Alwan, S., Reefhuis, J., Rasmussen, S.A., Friedman, J.M., Patterns of antidepressant medication use among pregnant women in a United States population. J. Clin. Pharmacol. 51:2 (2011), 264–270, 10.1177/0091270010373928.
5. Andersen, S.L., Greene-Colozzi, E.A., Sonntag, K.C., A novel, multiple symptom model of obsessive-compulsive-like behaviors in animals. Biol. Psychiatry 68:8 (2010), 741–747, 10.1016/j.biopsych.2010.05.011.
6. Anderson, G.M., Horne, W.C., Chatterjee, D., Cohen, D.J., The hyperserotonemia of autisma. Ann. N. Y. Acad. Sci. 600:1 (1990), 331–340, 10.1111/j. 1749-6632.1990. tb16893.x.
7. Ansorge, M.S., Zhou, M., Lira, A., Hen, R., Gingrich, J.A., Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science (New York, NY) 306:5697 (2004), 879–881, 10.1126/science.1101678.
8. Ansorge, M.S., Morelli, E., Gingrich, J.A., Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice. J. Neurosci. 28:1 (2008), 199–207, 10.1523/jneurosci.3973-07.2008.
9. Archer, J., Rodent sex differences in emotional and related behavior. Behav. Biol. 14:4 (1975), 451–479, 10.1016/s0091-6773(75)90636-7.
10. Aylward, E.H., Minshew, N.J., Goldstein, G., et al. MRI volumes of amygdala and hippocampus in non-mentally retarded autistic adolescents and adults. Neurology 53:9 (1999), 2145–2150.
11. Bairy, K.L., Madhyastha, S., Ashok, K.P., Bairy, I., Malini, S., Developmental and behavioral consequences of prenatal fluoxetine. Pharmacology 79:1 (2007), 1–11, 10.1159/000096645.
12. Bakker, M.K., Kölling, P., Van Den Berg, P.B., De Walle, H.E.K., De Jong van den Berg, L.T.W., Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands. Br. J. Clin. Pharmacol. 65:4 (2008), 600–606, 10.1111/j.1365-2125.2007.03048.x.
13. Bannerman, D.M., Grubb, M., Deacon, R.M., Yee, B.K., Feldon, J., Rawlins, J.N., Ventral hippocampal lesions affect anxiety but not spatial learning. Behav. Brain Res. 139:1–2 (2003), 197–213.
14. Baron-Cohen, S., Ashwin, E., Ashwin, C., Tavassoli, T., Chakrabarti, B., Talent in autism: hyper-systemizing, hyper-attention to detail and sensory hypersensitivity. Philos. Trans. R Soc. Lond. B Biol. Sci. 364:1522 (2009), 1377–1383, 10.1098/rstb.2008.0337.
15. Bayer, S.A., Altman, J., Russo, R.J., Zhang, X., Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat. Neurotoxicology 14:1 (1993), 83–144.
16. Bjerkenstedt, L., Flyckt, L., Overo, K.F., Lingjaerde, O., Relationship between clinical effects, serum drug concentration and serotonin uptake inhibition in depressed patients treated with citalopram. A double-blind comparison of three dose levels. Eur. J. Clin. Pharmacol. 28:5 (1985), 553–557.
17. Blazer, D.G., Kessler, R.C., McGonagle, K.A., Swartz, M.S., The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am. J. Psychiatry 151:7 (1994), 979–986, 10.1176/ajp.151.7.979.
18. Bonnin, A., Goeden, N., Chen, K., et al. A transient placental source of serotonin for the fetal forebrain. Nature 472:7343 (2011), 347–350, 10.1038/nature09972.
19. Boukhris, T., Sheehy, O., Mottron, L., Berard, A., Antidepressant use during pregnancy and the risk of autism spectrum disorder in children. JAMA Pediatr. 170:2 (2016), 117–124, 10.1001/jamapediatrics.2015.3356.
20. Braun, A.A., Graham, D.L., Schaefer, T.L., Vorhees, C.V., Williams, M.T., Dorsal striatal dopamine depletion impairs both allocentric and egocentric navigation in rats. Neurobiol. Learn. Mem. 97:4 (2012), 402–408, 10.1016/j.nlm.2012.03.004.
21. Braun, A.A., Amos-Kroohs, R.M., Gutierrez, A., et al. Dopamine depletion in either the dorsomedial or dorsolateral striatum impairs egocentric Cincinnati water maze performance while sparing allocentric Morris water maze learning. Neurobiol. Learn. Mem. 118 (2015), 55–63, 10.1016/j.nlm.2014.10.009.
22. Braun, A.A., Amos-Kroohs, R.M., Gutierrez, A., et al. 6-Hydroxydopamine-Induced dopamine reductions in the nucleus accumbens, but not the medial prefrontal cortex, impair cincinnati water maze egocentric and morris water maze allocentric navigation in male Sprague-Dawley rats. Neurotox. Res., 2016, 10.1007/s12640-016-9616-6.
23. Buhot, M.C., Martin, S., Segu, L., Role of serotonin in memory impairment. Ann. Med. 32:3 (2000), 210–221, 10.3109/07853890008998828.
24. Burgess, N., Maguire, E.A., O'Keefe, J., The human hippocampus and spatial and episodic memory. Neuron 35:4 (2002), 625–641.
25. Cabrera, T.M., Battaglia, G., Delayed decreases in brain 5-hydroxytryptamine2A/2C receptor density and function in male rat progeny following prenatal fluoxetine. J. Pharmacol. Exp. Ther. 269:2 (1994), 637–645.
26. Cabrera-Vera, T.M., Battaglia, G., Prenatal exposure to fluoxetine (Prozac) produces site-specific and age-dependent alterations in brain serotonin transporters in rat progeny: evidence from autoradiographic studies. J. Pharmacol. Exp. Ther. 286:3 (1998), 1474–1481.
27. Carreno, F.R., Donegan, J.J., Boley, A.M., et al. Activation of a ventral hippocampus-medial prefrontal cortex pathway is both necessary and sufficient for an antidepressant response to ketamine. Mol. Psychiatry, 2015, 10.1038/mp.2015.176.
28. Centers for Disease Control and Prevention (2012) Prevalence of Autism Spectrum Disorders − Autism and Developmental Disabilities Monitoring Network, 14 Sites, United States, 2008. vol 61, MMWR, p 1–24.
29. Chan, J.S., Snoeren, E.M., Cuppen, E., Waldinger, M.D., Olivier, B., Oosting, R.S., The serotonin transporter plays an important role in male sexual behavior: a study in serotonin transporter knockout rats. J. Sex. Med. 8:1 (2011), 97–108, 10.1111/j. 1743-6109.2010.01961.x.
30. Chandana, S.R., Behen, M.E., Juhasz, C., et al. Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism. Int. J. Dev. Neurosci. 23:2-3 (2005), 171–182, 10.1016/j.ijdevneu.2004.08.002.
31. Clancy, B., Darlington, R.B., Finlay, B.L., Translating developmental time across mammalian species. Neuroscience 105:1 (2001), 7–17.
32. Clancy, B., Finlay, B.L., Darlington, R.B., Anand, K.J., Extrapolating brain development from experimental species to humans. Neurotoxicology 28:5 (2007), 931–937, 10.1016/j.neuro.2007.01.014.
33. Cooper, W.O., Willy, M.E., Pont, S.J., Ray, W.A., Increasing use of antidepressants in pregnancy. Am. J. Obstet. Gynecol., 196(6), 2007, 544, 10.1016/j.ajog.2007.01.033 (e1-5).
34. Croen, L.A., Grether, J.K., Yoshida, C.K., Odouli, R., Hendrick, V., Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch. Gen. Psychiatry 68:11 (2011), 1104–1112, 10.1001/archgenpsychiatry.2011.73.
35. Dager, S.R., Wang, L., Friedman, S.D., et al. Shape mapping of the hippocampus in young children with autism spectrum disorder. AJNR Am. J. Neuroradiol. 28:4 (2007), 672–677.
36. Dawson, A.L., Ailes, E.C., Gilboa, S.M., et al. Antidepressant prescription claims among reproductive-aged women with private employer-sponsored insurance − United States 2008–2013. MMWR Morb. Mortal. Wkly. Rep. 65:3 (2016), 41–46, 10.15585/mmwr.mm6503a1.
37. Dayan, J., Creveuil, C., Herlicoviez, M., et al. Role of anxiety and depression in the onset of spontaneous preterm labor. Am. J. Epidemiol. 155:4 (2002), 293–301.
38. De Boer, S.F., Koolhaas, J.M., Defensive burying in rodents: ethology, neurobiology and psychopharmacology. Eur. J. Pharmacol. 463:1-3 (2003), 145–161.
39. Egaas, B., Courchesne, E., Saitoh, O., Reduced size of corpus callosum in autism. Arch. Neurol. 52:8 (1995), 794–801.
40. Engin, E., Treit, D., The role of hippocampus in anxiety: intracerebral infusion studies. Behav. Pharmacol. 18:5–6 (2007), 365–374, 10.1097/FBP.0b013e3282de7929.
41. Felix-Ortiz, A.C., Tye, K.M., Amygdala inputs to the ventral hippocampus bidirectionally modulate social behavior. J. Neurosci. 34:2 (2014), 586–595, 10.1523/jneurosci.4257-13.2014.
42. Forcelli, P.A., Heinrichs, S.C., Teratogenic effects of maternal antidepressant exposure on neural substrates of drug-seeking behavior in offspring. Addict. Biol. 13:1 (2008), 52–62, 10.1111/j.1369-1600.2007.00078.x.
43. Gaspar, P., Cases, O., Maroteaux, L., The developmental role of serotonin: news from mouse molecular genetics. Nat. Rev. Neurosci. 4:12 (2003), 1002–1012, 10.1038/nrn1256.
44. Gaynes, B.N., Gavin, N., Meltzer-Brody, S., et al., 2005 Perinatal depression: prevalence, screening accuracy, and screening outcomes. Evidence report/technology assessment (Summary)(119):1–8.
45. Gentile, S., Prenatal antidepressant exposure and the risk of autism spectrum disorders in children. Are we looking at the fall of Gods?. J Affective Disord. 182 (2015), 132–137, 10.1016/j.jad.2015.04.048.
46. Gidaya, N.B., Lee, B.K., Burstyn, I., Yudell, M., Mortensen, E.L., Newschaffer, C.J., In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder. J. Autism Dev. Disord. 44:10 (2014), 2558–2567, 10.1007/s10803-014-2128-4.
47. Gillott, A., Furniss, F., Walter, A., Anxiety in high-functioning children with autism. Autism 5:3 (2001), 277–286.
48. Glover, M.E., Clinton, S.M., Of rodents and humans: a comparative review of the neurobehavioral effects of early life SSRI exposure in preclinical and clinical research. Int. J. Dev. Neurosci., 2016, 10.1016/j.ijdevneu.2016.04.008.
49. Glover, M.E., Pugh, P.C., Jackson, N.L., et al. Early-life exposure to the SSRI paroxetine exacerbates depression-like behavior in anxiety/depression-prone rats. Neuroscience 284 (2015), 775–797, 10.1016/j.neuroscience.2014.10.044.
50. Gray, J.A., The Neuropsychology of Anxiety: An Enquiry into the Functions of the Septo-hippocampal System. 1982, Oxford University Press, Oxford, UK.
51. Hannon, J., Hoyer, D., Molecular biology of 5-HT receptors. Behav. Brain Res. 195:1 (2008), 198–213, 10.1016/j.bbr.2008.03.020.
52. Hansen, H.H., Mikkelsen, J.D., Long-term effects on serotonin transporter mRNA expression of chronic neonatal exposure to a serotonin reuptake inhibitor. Eur. J. Pharmacol. 352:2-3 (1998), 307–315.
53. Hansen, H.H., Sanchez, C., Meier, E., Neonatal administration of the selective serotonin reuptake inhibitor Lu 10-134-C increases forced swimming-induced immobility in adult rats: a putative animal model of depression?. J. Pharmacol. Exp. Ther. 283:3 (1997), 1333–1341.
54. Hansson, S.R., Mezey, E., Hoffman, B.J., Serotonin transporter messenger RNA in the developing rat brain: early expression in serotonergic neurons and transient expression in non-serotonergic neurons. Neuroscience 83:4 (1998), 1185–1201.
55. Harrington, R.A., Lee, L.C., Crum, R.M., Zimmerman, A.W., Hertz-Picciotto, I., Prenatal SSRI use and offspring with autism spectrum disorder or developmental delay. Pediatrics 133:5 (2014), e1241–e1248, 10.1542/peds.2013-3406.
56. Harris, S.S., Maciag, D., Simpson, K.L., Lin, R.C., Paul, I.A., Dose-dependent effects of neonatal SSRI exposure on adult behavior in the rat. Brain Res. 1429 (2012), 52–60, 10.1016/j.brainres.2011.10.025.
57. Hayes, R.M., Wu, P., Shelton, R.C., et al. Maternal antidepressant use and adverse outcomes: a cohort study of 228 pregnancies. Am. J. Obstetrics Gynecol., 207(1), 2012, 876, 10.1016/j.ajog.2012.04.028 49.e1-9.
58. Heindel, J.J., The fetal basis of adult disease: role of environmental exposures–introduction. Birth Defects Res. A Clin. Mol. Teratol. 73:3 (2005), 131–132, 10.1002/bdra.20119.
59. Heninger, G.R., Indoleamines: the role of serotonin in clinical disorders. Bloom, F.E., Kupker, D.J., (eds.) Psychopharmacology: the Fourth Generation of Progress, 2005, Raven Press, New York, 471–482.
60. Hitoglou, M., Ververi, A., Antoniadis, A., Zafeiriou, D.I., Childhood autism and auditory system abnormalities. Pediatr. Neurol. 42:5 (2010), 309–314, 10.1016/j.pediatrneurol.2009.10.009.
61. Homberg, J.R., Schubert, D., Gaspar, P., New perspectives on the neurodevelopmental effects of SSRIs. Trends Pharmacol. Sci. 31:2 (2010), 60–65, 10.1016/j.tips.2009.11.003.
62. Jacobson, L., Sapolsky, R., The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr. Rev. 12:2 (1991), 118–134, 10.1210/edrv-12-2-118.
63. Johnston, M.V., Coyle, J.T., Ontogeny of neurochemical markers for noradrenergic, GABAergic, and cholinergic neurons in neocortex lesioned with methylazoxymethanol acetate. J. Neurochem. 34:6 (1980), 1429–1441.
64. Kern, J.K., Trivedi, M.H., Garver, C.R., et al. The pattern of sensory processing abnormalities in autism. Autism 10:5 (2006), 480–494, 10.1177/1362361306066564.
65. Kessler, R.C., Bromet, E.J., The epidemiology of depression across cultures. Annu. Rev. Public Health 34 (2013), 119–138, 10.1146/annurev-publhealth-031912-114409.
66. Kessler, R.C., Berglund, P., Demler, O., et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289:23 (2003), 3095–3105, 10.1001/jama.289.23.3095.
67. Kessler, R.C., Berglund, P., Demler, O., Jin, R., Merikangas, K.R., Walters, E.E., Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62:6 (2005), 593–602, 10.1001/archpsyc.62.6.593.
68. Kessler, R.C., The costs of depression. Psychiat. Clin. North Am. 35:1 (2012), 1–14, 10.1016/j.psc.2011.11.005.
69. Khatri, N., Simpson, K.L., Lin, R.C., Paul, I.A., Lasting neurobehavioral abnormalities in rats after neonatal activation of serotonin 1A and 1B receptors: possible mechanisms for serotonin dysfunction in autistic spectrum disorders. Psychopharmacology (Berl) 231:6 (2014), 1191–1200, 10.1007/s00213-013-3242-2.
70. Kinsey, A.M., Wainwright, A., Heavens, R., Sirinathsinghji, D.J., Oliver, K.R., Distribution of 5-ht(5A), 5-ht(5B), 5-ht(6) and 5-HT(7) receptor mRNAs in the rat brain. Brain Res. Mol. Brain Res. 88:1–2 (2001), 194–198.
71. Klinger, G., Frankenthal, D., Merlob, P., et al. Long-term outcome following selective serotonin reuptake inhibitor induced neonatal abstinence syndrome. J. Perinatol. 31:9 (2011), 615–620, 10.1038/jp.2010.211.
72. Kohl, S., Wolters, C., Gruendler, T.O., Vogeley, K., Klosterkotter, J., Kuhn, J., Prepulse inhibition of the acoustic startle reflex in high functioning autism. PLoS One, 9(3), 2014, e92372, 10.1371/journal.pone.0092372.
73. Kugelberg, F.C., Apelqvist, G., Carlsson, B., Ahlner, J., Bengtsson, F., In vivo steady-state pharmacokinetic outcome following clinical and toxic doses of racemic citalopram to rats. Br. J. Pharmacol. 132:8 (2001), 1683–1690, 10.1038/sj.bjp.0704015.
74. Lauder, J.M., Bloom, F.E., Ontogeny of monoamine neurons in the locus coeruleus, raphe nuclei and substantia nigra of the rat. II. Synaptogenesis. J. Comp. Neurol. 163:3 (1975), 251–264, 10.1002/cne.901630302.
75. Lauder, J.M., Ontogeny of the serotonergic system in the rat: serotonin as a developmental signal. Ann. N. Y. Acad. Sci. 600 (1990), 297–313 (discussion 314).
76. Lebrand, C., Cases, O., Adelbrecht, C., et al. Transient uptake and storage of serotonin in developing thalamic neurons. Neuron 17:5 (1996), 823–835.
77. Lebrand, C., Cases, O., Wehrle, R., Blakely, R.D., Edwards, R.H., Gaspar, P., Transient developmental expression of monoamine transporters in the rodent forebrain. J. Comp. Neurol. 401:4 (1998), 506–524.
78. Lee, L.J., Lee, L.J., Neonatal fluoxetine exposure alters motor performances of adolescent rats. Dev. Neurobiol. 72:8 (2012), 1122–1132, 10.1002/dneu.20942.
79. Lee, L.J., Neonatal fluoxetine exposure affects the neuronal structure in the somatosensory cortex and somatosensory-related behaviors in adolescent rats. Neurotox. Res. 15:3 (2009), 212–223, 10.1007/s12640-009-9022-4.
80. Leekam, S.R., Nieto, C., Libby, S.J., Wing, L., Gould, J., Describing the sensory abnormalities of children and adults with autism. J. Autism Dev. Disord. 37:5 (2007), 894–910, 10.1007/s10803-006-0218-7.
81. Levinson-Castiel, R., Merlob, P., Linder, N., Sirota, L., Klinger, G., Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch. Pediatr. Adolesc. Med. 160:2 (2006), 173–176, 10.1001/archpedi.160.2.173.
82. Lisboa, S.F., Oliveira, P.E., Costa, L.C., Venancio, E.J., Moreira, E.G., Behavioral evaluation of male and female mice pups exposed to fluoxetine during pregnancy and lactation. Pharmacology 80:1 (2007), 49–56, 10.1159/000103097.
83. Maaswinkel, H., Gispen, W.H., Spruijt, B.M., Executive function of the hippocampus in social behavior in the rat. Behav. Neurosci. 111:4 (1997), 777–784.
84. MacNeil, B.M., Lopes, V.A., Minnes, P.M., Anxiety in children and adolescents with Autism Spectrum Disorders. Res. Autism Spectr. Disord. 3:1 (2009), 1–21, 10.1016/j.rasd.2008.06.001.
85. Maciag, D., Simpson, K.L., Coppinger, D., et al. Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry. Neuropsychopharmacology 31:1 (2006), 47–57, 10.1038/sj.npp.1300823.
86. Maciag, D., Williams, L., Coppinger, D., Paul, I.A., Neonatal citalopram exposure produces lasting changes in behavior which are reversed by adult imipramine treatment. Eur. J. Pharmacol. 532:3 (2006), 265–269, 10.1016/j.ejphar.2005.12.081.
87. Man, K.K., Tong, H.H., Wong, L.Y., Chan, E.W., Simonoff, E., Wong, I.C., Exposure to selective serotonin reuptake inhibitors during pregnancy and risk of autism spectrum disorder in children: a systematic review and meta-analysis of observational studies. Neurosci. Biobehav. Rev. 49 (2015), 82–89, 10.1016/j.neubiorev.2014.11.020.
88. Manhaes de Castro, R., Barreto Medeiros, J.M., Mendes da Silva, C., et al. Reduction of intraspecific aggression in adult rats by neonatal treatment with a selective serotonin reuptake inhibitor. Braz. J. Med. Biol. Res. 34:1 (2001), 121–124.
89. Marcus, S.M., Heringhausen, J.E., Depression in childbearing women: when depression complicates pregnancy. Prim. Care 36:1 (2009), 151–165, 10.1016/j.pop.2008.10.011 ix.
90. Michal, E.K., Effects of limbic lesions on behavior sequences and courtship behavior of male rats (Rattus norvegicus). Behaviour 44:3 (1973), 264–285.
91. Montgomery, K.C., The relation between fear induced by novel stimulation and exploratory behavior. J. Comp. Physiol. Psychol. 48:4 (1955), 254–260.
92. Narboux-Neme, N., Pavone, L.M., Avallone, L., Zhuang, X., Gaspar, P., Serotonin transporter transgenic (SERTcre) mouse line reveals developmental targets of serotonin specific reuptake inhibitors (SSRIs). Neuropharmacology 55:6 (2008), 994–1005, 10.1016/j.neuropharm.2008.08.020.
93. Noorlander, C.W., Ververs, F.F., Nikkels, P.G., van Echteld, C.J., Visser, G.H., Smidt, M.P., Modulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifelong behavioral abnormalities. PLoS One, 3(7), 2008, e2782, 10.1371/journal.pone.0002782.
94. O'keefe, J., Nadel, L., The Hippocampus as a Cognitive Map, vol. 3, 1978, Clarendon Press, Oxford.
95. Oberlander, T.F., Grunau, R., Mayes, L., et al. Hypothalamic-pituitary-adrenal (HPA) axis function in 3-month old infants with prenatal selective serotonin reuptake inhibitor (SSRI) antidepressant exposure. Early Hum. Dev. 84:10 (2008), 689–697, 10.1016/j.earlhumdev.2008.06.008.
96. Olexová, L., Štefánik, P., Kršková, L., Increased anxiety-like behaviourand altered GABAergic system in the amygdala and cerebellum of VPA ratsá An animal model of autism. Neurosci. Lett. 629 (2016), 9–14, 10.1016/j.neulet.2016.06.035.
97. Olivier, J.D., Blom, T., Arentsen, T., Homberg, J.R., The age-dependent effects of selective serotonin reuptake inhibitors in humans and rodents: a review. Prog. Neuro Psychopharmacol. Biol. Psychiatry 35:6 (2011), 1400–1408, 10.1016/j.pnpbp.2010.09.013.
98. Palanza, P., Animal models of anxiety and depression: how are females different?. Neurosci. Biobehav. Rev. 25:3 (2001), 219–233.
99. Persico, A.M., Mengual, E., Moessner, R., et al. Barrel pattern formation requires serotonin uptake by thalamocortical afferents, and not vesicular monoamine release. J. Neurosci. 21:17 (2001), 6862–6873.
100. Pinel, J.P., Symons, L.A., Christensen, B.K., Tees, R.C., Development of defensive burying in Rattus norvegicus: experience and defensive responses. J. Comp. Psychol. (Washington DC: 1983) 103:4 (1989), 359–365.
101. Popa, D., Lena, C., Alexandre, C., Adrien, J., Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development: evidence from sleep, stress, and behavior. J. Neurosci. 28:14 (2008), 3546–3554, 10.1523/jneurosci.4006-07.2008.
102. Rai, D., Lee, B.K., Dalman, C., Golding, J., Lewis, G., Magnusson, C., Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study. BMJ (Clin. Res. Ed.), 346, 2013, f2059, 10.1136/bmj.f2059.
103. Rodriguez-Porcel, F., Green, D., Khatri, N., et al. Neonatal exposure of rats to antidepressants affects behavioral reactions to novelty and social interactions in a manner analogous to autistic spectrum disorders. Anat. Rec. (Hoboken, NJ: 2007) 294:10 (2011), 1726–1735, 10.1002/ar.21402.
104. Rogers, S.J., Ozonoff, S., Annotation: what do we know about sensory dysfunction in autism? A critical review of the empirical evidence. J. Child Psychol. Psychiatry 46:12 (2005), 1255–1268, 10.1111/j. 1469–7610.2005.01431.x.
105. Ruat, M., Traiffort, E., Leurs, R., et al. Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc. Natl. Acad. Sci. U. S. A. 90:18 (1993), 8547–8551.
106. Sanz, E.J., De-las-Cuevas, C., Kiuru, A., Bate, A., Edwards, R., Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet (London, England) 365:9458 (2005), 482–487, 10.1016/s0140-6736(05)17865-9.
107. Sapolsky, R.M., Krey, L.C., McEwen, B.S., Glucocorticoid-sensitive hippocampal neurons are involved in terminating the adrenocortical stress response. Proc. Natl. Acad. Sci. U. S. A. 81:19 (1984), 6174–6177.
108. Schaefer, T.L., Grace, C.E., Braun, A.A., et al. Cognitive impairments from developmental exposure to serotonergic drugs: citalopram and MDMA. Int. J. Neuropsychopharmacol. 16:6 (2013), 1383–1394, 10.1017/s1461145712001447.
109. Schmitt, J.A., Jorissen, B.L., Sobczak, S., et al. Tryptophan depletion impairs memory consolidation but improves focussed attention in healthy young volunteers. J. Psychopharmacol. (Oxford, England) 14:1 (2000), 21–29.
110. Shepherd, J.K., Grewal, S.S., Fletcher, A., Bill, D.J., Dourish, C.T., Behavioural and pharmacological characterisation of the elevated zero-maze as an animal model of anxiety. Psychopharmacology (Berl) 116:1 (1994), 56–64.
111. Silber, B.Y., Schmitt, J.A., Effects of tryptophan loading on human cognition, mood, and sleep. Neurosci. Biobehav. Rev. 34:3 (2010), 387–407, 10.1016/j.neubiorev.2009.08.005.
112. Simpson, K.L., Weaver, K.J., de Villers-Sidani, E., et al. Perinatal antidepressant exposure alters cortical network function in rodents. Proc. Natl. Acad. Sci. U. S. A. 108:45 (2011), 18465–18470, 10.1073/pnas.1109353108.
113. Sussman, D., Leung, R.C., Vogan, V.M., et al. The autism puzzle: diffuse but not pervasive neuroanatomical abnormalities in children with ASD. NeuroImage Clin. 8 (2015), 170–179, 10.1016/j.nicl.2015.04.008.
114. Tecott, L.H., Maricq, A.V., Julius, D., Nervous system distribution of the serotonin 5-HT3 receptor mRNA. Proc. Natl. Acad. Sci. U. S. A. 90:4 (1993), 1430–1434.
115. Tecott, L.H., Serotonin and the orchestration of energy balance. Cell Metab. 6:5 (2007), 352–361, 10.1016/j.cmet.2007.09.012.
116. Vilaro, M.T., Cortes, R., Gerald, C., Branchek, T.A., Palacios, J.M., Mengod, G., Localization of 5-HT4 receptor mRNA in rat brain by in situ hybridization histochemistry. Brain Res. Mol. Brain Res. 43:1-2 (1996), 356–360.
117. Vorhees, C.V., Williams, M.T., Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat. Protoc. 1:2 (2006), 848–858, 10.1038/nprot.2006.116.
118. Vorhees, C.V., Williams, M.T., Assessing spatial learning and memory in rodents. ILAR J. 55:2 (2014), 310–332, 10.1093/ilar/ilu013.
119. Vorhees, C.V., Williams, M.T., Reprint of Value of water mazes for assessing spatial and egocentric learning and memory in rodent basic research and regulatory studies. Neurotoxicol. Teratol. 52:Pt A (2015), 93–108, 10.1016/j.ntt.2015.06.002.
120. Vorhees, C.V., Acuff-Smith, K.D., Schilling, M.A., Fisher, J.E., Moran, M.S., Buelke-Sam, J., A developmental neurotoxicity evaluation of the effects of prenatal exposure to fluoxetine in rats. Fundam. Appl. Toxicol. 23:2 (1994), 194–205.
121. Vorhees, C.V., Herring, N.R., Schaefer, T.L., et al. Effects of neonatal (+)-methamphetamine on path integration and spatial learning in rats: effects of dose and rearing conditions. Int. J. Dev. Neurosci. 26:6 (2008), 599–610, 10.1016/j.ijdevneu.2008.04.002.
122. Vorhees, C.V., Maze learning in rats: a comparison of performance in two water mazes in progeny prenatally exposed to different doses of phenytoin. Neurotoxicol. Teratol. 9:3 (1987), 235–241.
123. Weaver, K.J., Paul, I.A., Lin, R.C., Simpson, K.L., Neonatal exposure to citalopram selectively alters the expression of the serotonin transporter in the hippocampus: dose-dependent effects. Anat. Rec. (Hoboken, NJ: 2007) 293:11 (2010), 1920–1932, 10.1002/ar.21245.
124. Wei, F., Dubner, R., Zou, S., et al. Molecular depletion of descending serotonin unmasks its novel facilitatory role in the development of persistent pain. J. Neurosci. 30:25 (2010), 8624–8626, 10.1523/jneurosci.5389-09.2010.
125. Xu, T., Pandey, S.C., Cellular localization of serotonin(2A) (5HT(2A)) receptors in the rat brain. Brain Res. Bull. 51:6 (2000), 499–505.
126. Xu, Y., Sari, Y., Zhou, F.C., Selective serotonin reuptake inhibitor disrupts organization of thalamocortical somatosensory barrels during development. Brain Res. Dev. Brain Res. 150:2 (2004), 151–161, 10.1016/j.devbrainres.2003.02.001.
127. Yonkers, K.A., Wisner, K.L., Stewart, D.E., et al. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Obstetrics Gynecol. 114:3 (2009), 703–713, 10.1097/AOG.0b013e3181ba0632.
128. Zeskind, P.S., Stephens, L.E., Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics 113:2 (2004), 368–375.
129. Zhou, F.C., Sari, Y., Zhang, J.K., Expression of serotonin transporter protein in developing rat brain. Brain Res. Dev. Brain Res. 119:1 (2000), 33–45.
130. Zohar, I., Shoham, S., Weinstock, M., Perinatal citalopram does not prevent the effect of prenatal stress on anxiety, depressive-like behaviour and serotonergic transmission in adult rat offspring. Eur. J. Neurosci. 43:4 (2016), 590–600, 10.1111/ejn.13150.